WithdrawnNot Applicable

Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation

Stopped: abandoned project

France0Started 2020-03

Plain-language summary

This study describes Cefazolin pharmacokinetics variation to target levels during liver transplantation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age over 18 * patient undergoing liver transplantation * receiving Cefazolin as perioperative antibiotic prophylaxis to prevent surgical site infections Exclusion Criteria: * pregnant women * legal protection or protected adults * ongoing antibiotic treatment before liver transplantation * patient inability to receive information or express opposition to the study. * patient refusing participation

What they're measuring

Cefazolin blood concentration

Timeframe: Baseline up to 10 hours

Trial details

NCT IDNCT04280237

SponsorUniversity Hospital, Tours

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-03-18

View on ClinicalTrials.gov More Liver Transplant Infection trials